28.2.2021
Patients can digitally record benefits and side effects
Munich-based startup XO Life has developed a platform that allows patients to digitally record their treatment progress.
The Munich-based start-up XO Life (formerly Medikura) has developed an innovative digital platform that revolutionizes the monitoring of drug effectiveness and safety. The “ImpactMonitor” enables patients to digitally document treatment processes and relevant side effects. This data, including quality of life information, is systematically collected, pseudonymized and prepared for pharmaceutical companies and research institutes. They can use the data to improve pharmacovigilance and meet legal requirements.
Would you like to find out more or are you interested in XO Life?
Get in touch now, get a demo or answer individual questions in a personal conversation.
XO Life News
Discover even more news
Glenmark launcht eigenen Bereich für Malaria-Prophylaxe und -Therapie auf der ImpactMonitor™-Plattform von XO Life
Glenmark und XO Life bieten Patienten digitalen Support auf der ImpactMonitor™ Plattform an.
Dr. Gustav Klein and XO Life: Digital therapy support for users of Gastritol® Liquid for gastrointestinal complaints
Gastritol® Liquid now offers digital therapy support via XO Life's ImpactMonitor™ platform.
XO Life receives 7 Million Euros for the international expansion of its health platform as an alternative to Google, Facebook and Co.
XO Life secures €7 million for global expansion of its ImpactMonitor™ platform, a meta-platform for digital patient support.